Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1970 Sep 26;3(5725):735–737. doi: 10.1136/bmj.3.5725.735

Effect of Heparin on Serum Free-fatty-acids, Plasma Catecholamines, and the Incidence of Arrhythmias following Acute Myocardial Infarction

P G Nelson
PMCID: PMC1701629  PMID: 5472756

Abstract

The effect of intravenous heparin in a therapeutic dosage on cardiac arrhythmias in patients with indubitable acute myocardial infarction was investigated. The value of serum free-fatty-acids (F.F.A.s) and plasma catecholamines in the prediction of patients vulnerable to serious arrhythmias was also studied.

Heparin produced a significant rise in F.F.A., maximal within 10 minutes of injection, but did not increase the incidence of cardiac arrhythmias.

No relationship was found between the incidence of arrhythmias and the initial levels of F.F.A. or adrenaline. No correlation was obtained between F.F.A. and plasma catecholamine levels. Heparin did not have a consistent effect on plasma catecholamines. Initial control plasma noradrenaline concentrations, however, were found to be significantly correlated with the incidence of subsequent arrhythmias. It is suggested that the level of plasma noradrenaline may be a valuable predictive guide to those patients likely to develop significant arrhythmias after acute myocardial infarction.

Full text

PDF
736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balcon R., Jewitt D. E., Davies J. P., Oram S. A controlled trial of propranolol in acute myocardial infarction. Am Heart J. 1967 Oct;74(4):582–584. doi: 10.1016/0002-8703(67)90020-8. [DOI] [PubMed] [Google Scholar]
  2. Ceremuzyński L., Staszewska-Barczak J., Herbaczynska-Cedro K. Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc Res. 1969 Apr;3(2):190–197. doi: 10.1093/cvr/3.2.190. [DOI] [PubMed] [Google Scholar]
  3. Clausen J., Felsby M., Jorgensen F. S., Nielsen B. L., Roin J., Strange B. Absence of prophylactic effect of propranolol in myocardial infarction. Lancet. 1966 Oct 29;2(7470):920–924. doi: 10.1016/s0140-6736(66)90533-2. [DOI] [PubMed] [Google Scholar]
  4. GAZES P. C., RICHARDSON J. A., WOODS E. F. Plasma catechol amine concentrations in myocardial infarction and angina pectoris. Circulation. 1959 May;19(5):657–661. doi: 10.1161/01.cir.19.5.657. [DOI] [PubMed] [Google Scholar]
  5. Gupta D. K., Jewitt D. E., Young R., Hartog M., Opie L. H. Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet. 1969 Dec 6;2(7632):1209–1213. doi: 10.1016/s0140-6736(69)90749-1. [DOI] [PubMed] [Google Scholar]
  6. Kurien V. A., Oliver M. F. Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion. Lancet. 1966 Jul 16;2(7455):122–127. doi: 10.1016/s0140-6736(66)92420-2. [DOI] [PubMed] [Google Scholar]
  7. Kurien V. A., Yates P. A., Oliver M. F. Free fatty acids, heparin, and arrhythmias during experimental myocardial infarction. Lancet. 1969 Jul 26;2(7613):185–187. doi: 10.1016/s0140-6736(69)91424-x. [DOI] [PubMed] [Google Scholar]
  8. MOSINGER F. PHOTOMETRIC ADAPTATION OF DOLE'S MICRODETERMINATION OF FREE FATTY ACIDS. J Lipid Res. 1965 Jan;6:157–159. [PubMed] [Google Scholar]
  9. McDonald L., Baker C., Bray C., McDonald A., Restieaux N. Plasma-catecholamines after cardiac infarction. Lancet. 1969 Nov 15;2(7629):1021–1023. doi: 10.1016/s0140-6736(69)90637-0. [DOI] [PubMed] [Google Scholar]
  10. Norris R. M., Caughey D. E., Scott P. J. Trial of propranolol in acute myocardial infarction. Br Med J. 1968 May 18;2(5602):398–400. doi: 10.1136/bmj.2.5602.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Oliver M. F., Kurien V. A., Greenwood T. W. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968 Apr 6;1(7545):710–714. doi: 10.1016/s0140-6736(68)92163-6. [DOI] [PubMed] [Google Scholar]
  12. RICHARDSON J. A. CIRCULATING LEVELS OF CATECHOLAMINES IN ACUTE MYOCARDIAL INFARCTION AND ANGINA PECTORIS. Prog Cardiovasc Dis. 1963 Jul;6:56–62. doi: 10.1016/s0033-0620(63)80046-8. [DOI] [PubMed] [Google Scholar]
  13. Rutenberg H. L., Pamintuan J. C., Soloff L. A. Serum-free-fatty-acids and their relation to complications after acute myocardial infarction. Lancet. 1969 Sep 13;2(7620):559–564. doi: 10.1016/s0140-6736(69)90261-x. [DOI] [PubMed] [Google Scholar]
  14. Rutenberg H. L., Soloff L. A. Serum-free-fatty-acids and arrhythmias after acute myocardial infarction. Lancet. 1970 Jan 24;1(7639):198–198. doi: 10.1016/s0140-6736(70)90452-6. [DOI] [PubMed] [Google Scholar]
  15. Rutstein D. D., Castelli W. P., Nickerson R. J. Heparin and human lipid metabolism. Lancet. 1969 May 17;1(7603):1003–1008. doi: 10.1016/s0140-6736(69)91801-7. [DOI] [PubMed] [Google Scholar]
  16. Staszewska-Barczak J., Ceremuzynski L. The continuous estimation of catecholamine release in the early stages of myocardial infarction in the dog. Clin Sci. 1968 Jun;34(3):531–539. [PubMed] [Google Scholar]
  17. TROUT D. L., ESTES E. H., Jr, FRIEDBERG S. J. Titration of free fatty acids of plasma: a study of current methods and a new modification. J Lipid Res. 1960 Apr;1:199–202. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES